Single-Use Bioreactors Unwrap Commercial Manufacturing Options

Publication
Article
BioPharm InternationalBioPharm International-06-15-2019
Volume 2019 eBook
Issue 2
Pages: 24–27

This article provides a review of various 2000-L single-use bioreactors used by biopharmaceutical suppliers for commercial production.

Several companies have invested in 2000-L single-use bioreactors to expand production capabilities, including Thermo Fisher Scientific, GE Healthcare, Pall Biotech, and Sartorius Stedim Biotech. This article highlights the features, functions, and capacities of several large-volume bioreactors by these companies that are used in the market today.

Read this article in BioPharm International's Single-Use Systems 2019 eBook.

Article Details

BioPharm International
eBook: Single-Use Systems 2019
Vol. 32
June 2019
Pages: 24–27

Citation

When referring to this article, please cite it as A. Lowry, "Single-Use Bioreactors Unwrap Commercial Manufacturing Options," BioPharm International Single-Use Systems eBook (June 2019).

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.